https://novapharmanews.com/eu/news/chmp-july-2026-meeting-highlights-twelve-medicines 2026-07-24T17:16:48.608Z NovaPharmaNews en 2026-07-24T17:16:34.206Z CHMP July 2026: 12 New Medicines Recommended https://novapharmanews.com/eu/news/european-commission-approves-wegovy-pill-oral-glp1 2026-07-24T17:16:48.386Z NovaPharmaNews en 2026-07-24T17:16:32.997Z EC Approves Wegovy Pill, First Oral GLP-1 in EU Wegovy, semaglutide, Obesity, Metabolic Disorders https://novapharmanews.com/eu/news/chmp-recommends-obicetrapib-ubeslo-evlarco-cholesterol 2026-07-24T17:16:48.123Z NovaPharmaNews en 2026-07-24T17:16:31.698Z CHMP Backs Obicetrapib Ubeslo and Evlarco obicetrapib, Ubeslo, Evlarco, Cardiology, Metabolic Disorders https://novapharmanews.com/eu/news/ema-recommends-icotyde-icotrokinra-plaque-psoriasis 2026-07-24T17:16:30.528Z NovaPharmaNews en 2026-07-24T17:16:30.528Z EMA Backs Icotyde, First Oral IL-23R Psoriasis Drug Icotyde, icotrokinra, Dermatology, Immunology https://novapharmanews.com/eu/news/ema-recommends-susvimo-ranibizumab-implant-namd 2026-07-24T17:16:29.026Z NovaPharmaNews en 2026-07-24T17:16:29.026Z EMA Recommends Susvimo Implant for Wet AMD Susvimo, ranibizumab, Ophthalmology https://novapharmanews.com/apac/news/telix-illuccix-japan-phase-3-enrollment-complete 2026-07-24T17:10:08.139Z NovaPharmaNews en 2026-07-24T16:30:31.671Z Telix Completes Illuccix Japan Phase 3 Enrollment Illuccix, TLX591-Px, 68Ga-PSMA-11, Oncology, Prostate Cancer https://novapharmanews.com/uploads/articles/telix-illuccix-japan-phase-3-enrollment-complete.webp Telix Completes Illuccix Japan Phase 3 Enrollment https://novapharmanews.com/apac/news/nmpa-accepts-toripalimab-perioperative-nsclc-junshi 2026-07-24T17:26:25.693Z NovaPharmaNews en 2026-07-24T16:30:28.878Z NMPA Accepts Toripalimab Perioperative NSCLC sNDA toripalimab, Oncology, Lung Cancer https://novapharmanews.com/uploads/articles/nmpa-accepts-toripalimab-perioperative-nsclc-junshi.webp NMPA Accepts Toripalimab Perioperative NSCLC sNDA https://novapharmanews.com/apac/news/nmpa-approves-iza-bren-escc-china-systimmune 2026-07-24T17:26:29.043Z NovaPharmaNews en 2026-07-24T16:30:25.790Z NMPA Approves Iza-bren for ESCC in China iza-bren, izalontamab brengitecan, Oncology https://novapharmanews.com/uploads/articles/nmpa-approves-iza-bren-escc-china-systimmune.webp NMPA Approves Iza-bren for ESCC in China https://novapharmanews.com/apac/news/takeda-tak-003-india-first-dengue-vaccine-dcgi 2026-07-24T17:26:28.520Z NovaPharmaNews en 2026-07-24T16:30:22.931Z Takeda TAK-003 Wins India Dengue Vaccine Nod TAK-003, Vaccines, Infectious Diseases https://novapharmanews.com/uploads/articles/takeda-tak-003-india-first-dengue-vaccine-dcgi.webp Takeda TAK-003 Wins India Dengue Vaccine Nod https://novapharmanews.com/apac/news/nmpa-approves-ciprocopan-pnh-china-haisco 2026-07-24T17:08:43.277Z NovaPharmaNews en 2026-07-24T16:30:19.492Z NMPA Approves Ciprocopan for PNH in China ciprocopan, HSK39297, Rare Diseases, Hematology https://novapharmanews.com/uploads/articles/nmpa-approves-ciprocopan-pnh-china-haisco.webp NMPA Approves Ciprocopan for PNH in China https://novapharmanews.com/us/news/roche-fda-clearance-cobas-bv-cv-vaginitis-assay 2026-07-24T17:09:24.616Z NovaPharmaNews en 2026-07-24T16:21:53.991Z Roche Gets FDA Clearance for cobas BV/CV Assay Women's Health, Diagnostics https://novapharmanews.com/uploads/articles/roche-fda-clearance-cobas-bv-cv-vaginitis-assay.webp Roche Gets FDA Clearance for cobas BV/CV Assay https://novapharmanews.com/us/news/fda-accepts-bridgebio-encaleret-nda-adh1 2026-07-24T17:23:18.849Z NovaPharmaNews en 2026-07-24T16:21:50.803Z FDA Accepts BridgeBio Encaleret NDA for ADH1 encaleret, Rare Diseases, Endocrinology https://novapharmanews.com/uploads/articles/fda-accepts-bridgebio-encaleret-nda-adh1.webp FDA Accepts BridgeBio Encaleret NDA for ADH1 https://novapharmanews.com/us/news/fda-accepts-daraxonrasib-nda-metastatic-pancreatic-cancer 2026-07-24T17:23:27.594Z NovaPharmaNews en 2026-07-24T16:21:47.787Z FDA Accepts Daraxonrasib NDA for Pancreatic Cancer daraxonrasib, Oncology https://novapharmanews.com/uploads/articles/fda-accepts-daraxonrasib-nda-metastatic-pancreatic-cancer.webp FDA Accepts Daraxonrasib NDA for Pancreatic Cancer https://novapharmanews.com/us/news/fda-accepts-dyne-bla-z-rostudirsen-exon-51-dmd 2026-07-24T17:17:46.913Z NovaPharmaNews en 2026-07-24T16:21:44.645Z FDA Accepts Dyne BLA for z-Rostudirsen in DMD z-rostudirsen, DYNE-251, Rare Diseases, Neurology https://novapharmanews.com/uploads/articles/fda-accepts-dyne-bla-z-rostudirsen-exon-51-dmd.webp FDA Accepts Dyne BLA for z-Rostudirsen in DMD https://novapharmanews.com/us/news/fda-approves-gsk-jideytro-zidesamtinib-ros1-nsclc 2026-07-24T17:08:42.734Z NovaPharmaNews en 2026-07-24T16:21:41.100Z FDA Approves GSK Jideytro for ROS1+ NSCLC Jideytro, zidesamtinib, Oncology, Lung Cancer https://novapharmanews.com/uploads/articles/fda-approves-gsk-jideytro-zidesamtinib-ros1-nsclc.webp FDA Approves GSK Jideytro for ROS1+ NSCLC